Baxter’s BioScience business has manufacturing expertise in plasma fractionation technology.
Baxter’s plasma fractionation method is increasingly more efficient and helps improve product yields from plasma donations. Plasma contains thousands of different therapeutic proteins, and fractionation concentrates the necessary proteins. The company’s experience in plasma fractionation has resulted in the development of reliable and innovative therapies that ensure the treatment of various chronic conditions.
A sterile, nonpyrogenic preparation of albumin in a single-dosage
Sterile, stable, lyophilized preparation of purified alpha 1-proteinase inhibitor
